THI & Rice Baker Institute to Host Stem Cell Policy Discussion: Stem Cell Therapies 2020: Are We There Yet?

Stem cell-based inventions offer great hope to patients with debilitating illnesses and injuries. However, only a limited number of treatments are approved for clinical use. A panel of experts will describe the stem cell therapy landscape on March 6, 2020 at the Baker Institute.

Kirstin R.W. Matthews, PhD, fellow in science and technology policy at the Baker Institute, will moderate a panel discussion entitled Stem Cell Therapies 2020: Are We There Yet? 

Texas Heart Institute’s Emerson Perin, MD, PhD and freelance journalist Laura Beil, will highlight the available treatments today and describe why even negative clinical data can lead to new interventions. They will also evaluate recent incidents of unregulated stem cells harming patients.

Dr. Perin, Texas Heart Institute’s Medical Director, is a world-renowned cardiologist known for his leadership in the development of stem cell therapies for cardiovascular diseases. Laura Beil is the award-winning host of Bad Batch and Dr. Death podcasts.

This event is part of an annual policy lecture series co-sponsored by the Rice University Baker Institute Center for Health and Biosciences and the Texas Heart Institute.

The Baker Institute and THI launched the policy lecture series in 2016 to educate the public on the critical intersection of science, medicine, and policy in stem cell research at the state and national levels. 

Funding for the program has been provided by a grant from the George and Mary Josephine Hamman Foundation.

Learn More about the event and Register Online 


Follow @BakerCHB on Twitter and join the conversation online with #BakerStemCell.